eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank

3/2010
vol. 35
 
Share:
Share:
more
 
 

Review paper
Use of diet supplements, synthetic drugs and herbal remedies with immunotropic activity during pregnancy. I. Echinacea

Ewa Skopińska-Różewska
,
Krzysztof Makuch

(Centr Eur J Immunol 2010; 35 (3): 183-185)
Online publish date: 2010/10/05
Article file
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
 
Fetus is a kind of semiallogeneic graft, its tissues contain histocompatibility antigens of maternal and paternal origin. The lack of rejection of fetus by the maternal immune system is the result of delicate interplay between many factors at the maternal-fetal interface. Among them, a family of pregnancy-specific glycoproteins (PSGs) and some cytokines (IL-10, IL-6, TGFb1) play immu­nomodulatory roles during pregnancy and has also some role in placental vascular morphogenesis. There is evidence that PSGs can modulate the secretion of important pro-angiogenic factors , TGFb1 and VEGFA, by different cell types involved in the development of the placenta. Abnormally low levels of PSG1s in maternal serum may lead to complications, including spontaneous abortion. It was reported, that the levels of PSG1 and pregnancy- associated plasma protein A (PAPP-A) in first-trimester maternal serum are influenced by smoking [1-5].
Many women use herbal remedies during pregnancy. However, data regarding safety of this kind of treatment is sparse and very limited . Moreover, women often do not inform their doctors about the use of herbal remedies during pregnancy and lactation. A survey of 578 pregnant women in the eastern United States reported that 45% of them had used herbal drugs. In Australia, 36% of 588 pregnant women used herbal medicines. In Nigeria, 67.5% of 595 women had used herbal remedies during pregnancy. In Norway study 57.8% of pregnant responders used herbal medicines. In Switzerland, pilot study was performed on small group of 139 women. During pregnancy 96%, and within the lactation period 84% of the women consumed at least 1 natural remedy [6-10].
Laws regulating production and distribution of herbal medicines, especially in developing countries, are poor. Access to herbal remedies is easy and unrestricted, because they are often introduced to the market as food supplements. Medical herbs are often regarded as gentle and safe. However, there are no rigorous studies of their safety during pregnancy [11].
Plant-based immune stimulation provides an alternative to conventional therapy of infections, especially in immunocompromised patients. Conventional chemotherapy may often result in undesirable effects. Animal and human studies revealed a modulatory effect of various antibiotics on humoral and cellular immune response. For example, ampicillin and other antibiotics from this group suppress some parameters of cellular, and enhance some parameters of humoral immunity [12-16]. Furthermore, treatment of pregnant mice with ampicillin resulted in abnormalities in immunological response to antigens of 30-day old offspring of these mice. A lowering of cellular immunity, accom­panied by a decrease in T lymphocyte percentage in lymph nodes, and an increase of humoral immune response were observed [17-19].

Echinacea

Echinacea purpurea and Echinacea angustifolia are some of the most significant medicinal herbs. Native to the North American prairies they are now cultivated in many countries. Echinacea extracts contain many compounds with proved immunomodulatory, antioxidant and anti-inflammatory activities. They may be used both internally and externally to treat respiratory infections, skin burns and skin infections [20]. Scientific evidence for the safe use of this herb during pregnancy and lactation was not available for a long time. Only one prospective study suggested that gestational use of Echinacea during organogenesis is not associated with an increased risk for major malformations [21]. In 2006 Perri searched 7 electronic databases, compiled data according to the grade of evidence found, and concluded, that there is a good scientific evidence from a prospective cohort study that Echinacea is non-teratogenic when used during pregnancy. Low-level evidence based on expert opinion showed safety of Echinacea consumption during lactation [22]. However, there are no formal studies which may exclude the possibility, that the absence of malformations in the living births resulted from the fact that consuming Echinacea may promote spontaneous abortions.
Animal studies of this problem are scarce. However, in 2006 Chow reported unwanted effects of Echinacea feeding in pregnant mice. Pregnancy-induced elevation in splenic lymphocytes and hemopoietic cells was eliminated by feeding pregnant mice Echinacea. Moreover, the number of viable fetuses was reduced [23].
In an experiment on mice Barcz et al. found that two Echinacea drugs lowered the number of embryos in litter and significantly diminished the vascular endothelial growth factor (VEGF) and the basic fibroblast growth factor (bFGF) content of embryos tissue. These studies showed that the most important mechanism influencing fetal development in case of Echinacea sp. intake is its influence on angiogenic activity of developing tissues [24].
Vascular endothelial growth factor and bFGF are known as the most potential angiogenesis promoters. Vascular endothelial growth factor plays a crucial role in organo­genesis (liver and pancreas induction, kidney glomerulus, bone and nervous system development). Moreover, VEGF and bFGF take part in placentation and cytotrophoblast proliferation during pregnancy [25-27].

References

 1. Snyder S (2000): Human pregnancy-specific glycoproteins functions as immunomodulators in vitro by inducing secretion of IL-10 and IL-6 in human monocytes. http://www.stormingmedia.us/10/1044/A104444.html  
2. Ha CT, Wu JA, Imak S, et al. (2010): Human pregnancy-specific beta-1-glycoprotein 1 (PSG1) has a potential role in placental vascular morphogenesis. Biol Reprod 83: 27-35.  
3. Pihl K, Christiansen M (2010): Pregnancy-specific beta-1-glycoprotein in first-trimester maternal serum is influenced by smoking. Clin Chem 56: 485-487.  
4. Gajewska J, Ceran A, Chełchowska M, et al. (2008): Effect of maternal smoking on concentrations of the pregnancy-associated plasma protein A (PAPP-A) and free beta subunit of chorionic gonadotropin (beta hCG) in the first trimester of pregnancy. Przegl Lek 65: 479-482.  
5. Wu JA, Johnson BL, Chen Y, et al. (2008): Murine pregnancy- specific glycoprotein 23 induces the proangiogenic factors TGFb1 and VEGFA in cell types involved in vascular remodeling in pregnancy. Biol Reprod 79: 1054-1061.  
6. Low Tog T (2009): The use of botanicals during pregnancy and lactation. Altern Ther Health Med 15: 54-58.  
7. Fakeye TO, Adisa R, Musa IE (2009): Attitude and use of herbal medicines among pregnant women in Nigeria. BMC Complement Altern Med 9:53 http://www.biomedcentral.com/­1472-6882/9/53/prepub.  
8. Holst L, Wright D, Haavik S, Nordeng H (2009): The use and the user of herbal remedies during pregnancy. J Altern Complement Med 15: 787-792.  
9. Holst L, Wright D, Nordeng H, Haavik S (2009): Use of herbal preparations during pregnancy:focus group discussion among expectant mothers attending a hospital antenatal clinic in Norwich, UK. Complement Ther Clin Pract 15: 225-229.
10. Gut E, Melzer J, von Mandach U, Saller R (2004): Natural remedies during pregnancy and lactation. Gynakol Geburtshilfliche Rundsch 44: 233-237.
11. Marcus DM, Snodgrass WR (2005): Do no harm: avoidance of herbal medicines during pregnancy. Obstet Gynecol 106: 409-410.
12. Skopińska-Różewska E, Kamiński M, Nowaczyk M, et al. (1985): Immunomodulatory action of ampicillin. Folia Biol(Praha) 31: 200-212.
13. Wąsik M, Skopińska-Różewska E, Święcicka G (1981): The effect of ampicillin on antibody – dependent ( ADCC) and lectin-induced (LICC)cellular cytotoxicity.Arch Immun Ther Exper 29: 373-377.
14. Mościcka-Wesołowska M, Skopińska-Różewska E (1981): The effect of ampicillin on skin graft survival and antibody nresponse in B6A F1 mice. Arch Immun Ther Exper 39: 379-383.
15. Mościcka-Wesołowska M, Skopińska-Różewska E, Morzycka M, et al. (1983): Ampicillin effect on lymphatic tissue of mice and its reaction to SRBC. Acta Physiol Pol 34: 369-381.
16. Skopińska-Różewska E, Nowaczyk M, Lao M, Górski AJ (1981): The effect of ampicillin on the expression of FcG receptors on human peripheral blond lymphocytes. Biomedicine 35: 41-42.
17. Skopińska-Różewska E, Mościcka-Wesołowska M, Wasiutyński A, et al. (1985): Lymphatic system of mice born from mothers treated with ampicillin or cloxacillin during gestation. Arch Immunol Ther Exper 34: 203-209.
18. Włodarska B, Bany J, Marczak M, et al. (1987): Altered immune reactivity of mice born from mothers treated with ampicillin during gestation. Folia Biol (Praha) 33: 211-215.
19. Skopińska-Różewska E, Barcz E (2007): The effect of natural and synthetic substances administered to mice during pregnancy on the development of immune system of their progeny . In: Aktualne problemy immunodiagnostyki i immunotoksykologii, AK Siwicki, E Skopińska-Różewska (ed.). SPW EDYCJA, Olsztyn, pp. 37-50.
20. Skopińska-Różewska E, Strzelecka H, Wasiutyński A, et al. (2008): Aqueous and hydro-alcoholic extracts of Echinacea purpurea (L) Moench as traditional herbal remedies with immunotropic activity. Centr Eur J Immunol 33: 78-82.
21. Gallo M, Sarkar M, Au W, et al. (2000): Pregnancy outcome following gestational exposure to Echinacea. A prospective controlled study. Arch Intern Med 160: 3141-3143.
22. Perri D, Dugoua JJ, Mills E, Koren G (2006): Safety and efficacy of Echinacea (Echinacea angustifolia, e.purpurea and e.pallida) during pregnancy and lactation. Can J Clin Pharmacol 13: 262-267.
23. Choe G, Johns T, Miller SC (2006): Dietary Echinacea purpurea during murine pregnancy: effect on maternal hemopoiesis and fetal growth. Biol Neonate 89: 133-138.
24. Barcz E, Sommer E, Nartowska J, et al. (2007): Influence of Echinacea purpurea intake during pregnancy on fetal growth and tissue angiogenic activity. Folia Histochem Cytobiol 45S1: S35-S39.
25. Wei P, Yu FQ, Chen XL, et al. (2004): VEGF, bFGF and their receptors at the fetal-maternal interface of the rhesus monkey. Placenta 25: 184-196.
26. Zygmunt M, Herr F, Münstedt K, et al. (2003): Angiogenesis and vasculogenesis in pregnancy Eur J Obstet Gynecol Reprod Biol 110: S10-S18.
27. Coultas L, Chawengsaksophak K, Rossant J (2005): Endothelial cells and VEGF in vascular development. Nature 5: 937-945.
Copyright: © 2010 Polish Society of Experimental and Clinical Immunology This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
FEATURED PRODUCTS
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe